Characterization of lesions of the breast with proton MR spectroscopy: comparison of carcinomas, benign lesions, and phyllodes tumors.
暂无分享,去创建一个
Winnie C W Chu | D. Yeung | G. Tse | W. Chu | David K W Yeung | Gary M K Tse | B. Law | H. Cheung | L. Pang | Fred Y l Kung | Humairah S Cheung | Lai-Man Pang | Bonita K B Law | Fred Y L Kung
[1] T. Nishikawa,et al. Angiogenesis as a predictor of long-term survival for 377 Japanese patients with breast cancer , 2001, Breast Cancer Research and Treatment.
[2] Robert E. Lenkinski,et al. The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy , 2001, Breast Cancer Research and Treatment.
[3] Wei-Tse Yang,et al. Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases. , 2002, Radiology.
[4] D. Carter,et al. Rosen's Breast Pathology, 2nd ed. , 2002 .
[5] R. Scolyer,et al. Increased p53 Protein Expression in Malignant Mammary Phyllodes Tumors , 2002, Modern Pathology.
[6] H. Degani,et al. Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis. , 2002, Cancer research.
[7] Mike E. Davies,et al. Tensor Decompositions, State of the Art and Applications , 2009, 0905.0454.
[8] D. Yeung,et al. Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopy--initial results. , 2001, Radiology.
[9] H. Degani,et al. Differential routing of choline in implanted breast cancer and normal organs , 2001, Magnetic resonance in medicine.
[10] G. Tse,et al. Increased microvessel density in malignant and borderline mammary phyllodes tumours , 2001, Histopathology.
[11] M. Cenci,et al. Immunohistochemical expression of p53, nm23-HI, Ki67 and DNA ploidy: correlation with lymph node status and other clinical pathologic parameters in breast cancer. , 1999, Anticancer research.
[12] I. Gribbestad,et al. Characterization of neoplastic and normal human breast tissues with in vivo 1H MR spectroscopy , 1999, Journal of magnetic resonance imaging : JMRI.
[13] Z. Bhujwalla,et al. Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. , 1999, Cancer research.
[14] I. Gribbestad,et al. In vivo 1H MRS of normal breast and breast tumors using a dedicated double breast coil , 1998, Journal of magnetic resonance imaging : JMRI.
[15] Barbara L. Smith,et al. Evaluating human breast ductal carcinomas with high-resolution magic-angle spinning proton magnetic resonance spectroscopy. , 1998, Journal of magnetic resonance.
[16] T. Powles,et al. Measurements of human breast cancer using magnetic resonance spectroscopy: a review of clinical measurements and a report of localized 31P measurements of response to treatment , 1998, NMR in biomedicine.
[17] R. Lenkinski,et al. Human breast lesions: characterization with proton MR spectroscopy. , 1998, Radiology.
[18] Vanhamme,et al. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge , 1997, Journal of magnetic resonance.
[19] W. Mackinnon,et al. Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. , 1997, Radiology.
[20] H. Degani,et al. Variations in energy and phospholipid metabolism in normal and cancer human mammary epithelial cells. , 1996, Anticancer research.
[21] N. Weidner,et al. Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma. , 1994, The American journal of pathology.
[22] I. Gribbestad,et al. 1H NMR spectroscopic characterization of perchloric acid extracts from breast carcinomas and non‐involved breast tissue , 1994, NMR in biomedicine.
[23] I. Gribbestad,et al. In vitro proton NMR spectroscopy of extracts from human breast tumours and non-involved breast tissue. , 1993, Anticancer research.
[24] M. Leach,et al. Phospholipid metabolites, prognosis and proliferation in human breast carcinoma , 1993, NMR in biomedicine.
[25] F Pozza,et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. , 1992, Journal of the National Cancer Institute.
[26] M. Leach,et al. The phosphocholine and glycerophosphocholine content of an oestrogen-sensitive rat mammary tumour correlates strongly with growth rate. , 1991, British Journal of Cancer.
[27] M. Moerland,et al. Human breast cancer in vivo: H-1 and P-31 MR spectroscopy at 1.5 T. , 1988, Radiology.
[28] N. Lemoine,et al. Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variables , 1987, The Journal of pathology.
[29] S. Robbins,et al. Pathologic basis of disease , 1974 .